• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AdaptHealth Corp. (AHCO)

By: The Law Offices of Frank R. Cruz via Business Wire
December 21, 2023 at 11:00 AM EST

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 26, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) common stock: (1) between August 4, 2020 and February 27, 2023, inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to the Company’s January 2021 secondary public offering (the “SPO”).

If you are a shareholder who suffered a loss, click here to participate.

On or around January 5, 2021, Adapt Health conducted its SPO, selling 8,450,000 shares of common stock at $33 per share.

On February 27, 2023, AdaptHealth announced a loss of $0.02 per share for the fourth quarter of 2022, significantly less than the gain of $0.27 per share that analysts and investors had expected. The Company also reduced its 2023 guidance, lowering revenue expectance by over 1.5%. The Company stated that the disappointing results were due to “lower diabetes growth in the second half than anticipated.”

On this news, AdaptHealth’s stock price fell $5.99, or 27.3%, to close at $15.99 per share on February 28, 2023, thereby injuring investors.

The complaint filed in this class action alleges Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically: (1) AdaptHealth misstated the Company’s true ability to generate organic growth in its diabetes segment; (2) AdaptHealth engaged in improper upcoding and other illicit billing practices; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased or otherwise acquired AdaptHealth common stock during the Class Period, you may move the Court no later than December 26, 2023 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231221000426/en/

Contacts

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

fcruz@frankcruzlaw.com

www.frankcruzlaw.com

More News

View More
Equinix Stock Rises Despite Lower Revenue Guidance
Today 15:25 EDT
Via MarketBeat
Tickers EQIX META MSFT
MongoDB: It’s No Trick, This AI Play Is a Treat
Today 14:18 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers MDB
$14B Japanese Facility Signals TSMC's Bold AI Strategy
Today 13:32 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers SONY TSM
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks
Today 12:41 EDT
Via MarketBeat
Tickers AMGN RPRX VRTX ZBIO
Meta Platforms Stock Falls Despite Strong Growth—Here’s Why
Today 11:34 EDT
Via MarketBeat
Tickers GOOGL META MSFT

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.38
+21.51 (9.65%)
AAPL  270.97
-0.43 (-0.16%)
AMD  257.59
+2.75 (1.08%)
BAC  53.60
+0.57 (1.07%)
GOOG  281.74
-0.16 (-0.06%)
META  649.31
-17.16 (-2.58%)
MSFT  517.36
-8.40 (-1.60%)
NVDA  203.33
+0.44 (0.22%)
ORCL  262.87
+5.98 (2.33%)
TSLA  455.58
+15.48 (3.52%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap